IJU case reports · 2026
Malignant/Sarcomatous Transformation of Mixed Epithelial and Stromal Tumor of the Kidney: A Case Report.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arinami Kentaro, Ito Kozue, Hasegawa Go, Takizawa Yurie, Ikeda Yohei, Hara Noboru, Nishiyama Tsutomu
Аннотация
INTRODUCTION: Malignant transformation of mixed epithelial and stromal tumors of the kidney (MESTK) is extremely rare.
CASE PRESENTATION: A 39-year-old man with gross hematuria was suspected to have renal cell carcinoma, measuring 13 cm in diameter. No distant metastases were observed. The patient underwent laparoscopic left nephrectomy. Histopathological examination revealed malignant sarcomatous transformation of MESTK. Immunohistochemically, the tumor was positive for PAX8, CD10, and desmin, as well as for estrogen, progesterone, and androgen receptors. Comprehensive genomic profiling did not yield any treatment recommendations or relevant information. The patient will be closely monitored for any signs of recurrence or metastasis.
CONCLUSION: The associated prognosis for patients with nonmetastatic MESTKs exhibiting malignant transformation is unknown; however, strict follow-up is recommended due to the histological grade of malignancy and local invasion.
CASE PRESENTATION: A 39-year-old man with gross hematuria was suspected to have renal cell carcinoma, measuring 13 cm in diameter. No distant metastases were observed. The patient underwent laparoscopic left nephrectomy. Histopathological examination revealed malignant sarcomatous transformation of MESTK. Immunohistochemically, the tumor was positive for PAX8, CD10, and desmin, as well as for estrogen, progesterone, and androgen receptors. Comprehensive genomic profiling did not yield any treatment recommendations or relevant information. The patient will be closely monitored for any signs of recurrence or metastasis.
CONCLUSION: The associated prognosis for patients with nonmetastatic MESTKs exhibiting malignant transformation is unknown; however, strict follow-up is recommended due to the histological grade of malignancy and local invasion.